✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Dizal Pharmaceutical Co Ltd

Common Name
Dizal Pharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,009
Ticker
688192
Exchange
Shanghai Stock Exchange
Description
Dizal (Jiangsu) Pharmaceutical Co., Ltd. specializes in the research, development, and commercialization of innovative therapeutics, focusing primarily on oncology and immunological diseases. As a pha...

Dizal Pharmaceutical's Revenues Data

Explore Dizal Pharmaceutical's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
114,434,203a
CN¥801,135,558
49,314,288a
CN¥359,900,621
12,844,891a
CN¥91,288,640
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Dizal Pharmaceutical’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Dizal Pharmaceutical's Annual Report 2025